Viewing Study NCT02725268


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-04-22 @ 2:35 AM
Study NCT ID: NCT02725268
Status: COMPLETED
Last Update Posted: 2021-11-24
First Post: 2016-03-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer
Sponsor: Millennium Pharmaceuticals, Inc.
Organization: